Sun, Dec 28, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

GFIA: Less than 50% of new Asian hedge funds were L/S equity funds, over 50% of funds smaller than $50m

Friday, July 30, 2010

Opalesque Industry Update - GFIA pte ltd has released the 14th edition of its long-running review of the Asian hedge fund industry. In this paper, GFIA provides an overview of the Asian hedge fund industry based on industry growth, geographic and strategy trends, hedge funds capacity and characteristics specific to Asian strategies that GFIA has monitored since it commenced coverage in 1998. Some findings include:

- Fewer than 50% of newly launched funds this year were long/short equities funds, with notable increases in strategies uncorrelated to equity markets.

- Generally, few managers are seeing inflows and the asset raising environment remains tough. Currently more than 50% of Asian hedge funds have asset sizes of less than US$50m.

Peter Douglas CAIA, principal of GFIA, commented: “While the Asian hedge fund industry continues to mature in terms of the breadth of the investment opportunities, and the depth of the operational proposition it offers investors, asset sizes remain constrained. There’s an excellent current opportunity for investors to engage with small, motivated, managers in Asia, with interesting strategies and well resourced businesses.“ Corporate website: Source

- FG

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its